Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
296
-
Total 13F shares, excl. options
-
44.8M
-
Shares change
-
+34.9K
-
Total reported value, excl. options
-
$3.43B
-
Value change
-
-$8.49M
-
Put/Call ratio
-
1.23
-
Number of buys
-
171
-
Number of sells
-
-120
-
Price
-
$76.69
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q3 2019
335 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q3 2019.
REPLIGEN CORP - COMMON STOCK (RGEN) has 296 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.8M shares
of 56.2M outstanding shares and own 79.66% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.64M shares), VANGUARD GROUP INC (4.37M shares), Invesco Ltd. (2.55M shares), STATE STREET CORP (2.35M shares), WELLINGTON MANAGEMENT GROUP LLP (2.32M shares), FRED ALGER MANAGEMENT, LLC (1.38M shares), Conestoga Capital Advisors, LLC (1.28M shares), FEDERATED INVESTORS INC /PA/ (1.14M shares), 12 West Capital Management LP (994K shares), and MACQUARIE GROUP LTD (875K shares).
This table shows the top 296 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.